Functional consequences of attenuating mutations in the haemagglutinin-neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain

Journal of General Virology

Volumn 88, Issue 9, 2007, Pages 2533-2541

  Malik, Tahir ^a   Wolbert, Candie ^a   Mauldin, Jeremy ^b   Sauder, Christian ^a   Carbone, Kathryn M ^a   Rubin, Steven A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; HN PROTEIN; HYBRID PROTEIN; ISOLEUCINE; SERINE; THREONINE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNIZATION; MUMPS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; SYMPTOM; VIRUS ATTENUATION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; CELL LINE; CHICK EMBRYO; DNA PRIMERS; DNA-DIRECTED DNA POLYMERASE; DNA-DIRECTED RNA POLYMERASES; GENE FUSION; HELA CELLS; HN PROTEIN; HUMANS; KINETICS; MUMPS VIRUS; MUTATION; NEURAMINIDASE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; THREONINE; VIRAL FUSION PROTEINS; VIRAL PROTEINS;

MUMPS VIRUS;

EID: 34548225577     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82935-0     Document Type: Article

References (64)

1. Afzal, M. A., Yates, P. J. & Minor, P. D. (1998). Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J Infect Dis 177, 265-266.
2. Aguilar, H. C., Matreyek, K. A., Filone, C. M., Hashimi, S. T., Levroney, E. L., Negrete, O. A., Bertolotti-Ciarlet A., Choi, D. Y., McHardy, I. & other authors (2006). N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 80, 4878-4889.
3. Amexis, G., Fineschi, N. & Chumakov, K. (2001). Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287, 234-241.
4. Amexis, G., Rubin, S., Chatterjee, N., Carbone, K. & Chumakov, K. (2003). Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. J Med Virol 70, 284-286.
5. Aminoff, D. (1961). Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J 81, 384-392.
6. Aygun, A. D., Kabakus, N., Celik, I., Turgut, M., Yoldas, T., Gok, U. & Guler, R. (2001). Long-term neurological outcome of acute encephalitis. J Trop Pediatr 47, 243-247.
7. Bagai, S. & Lamb, R. A. (1995). Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein. Virology 209, 250-256.
8. Bairoch, A., Bucher, P. & Hofmann, K. (1997). The PROSITE database, its status in 1997. Nucleic Acids Res 25, 217-221.
9. Bang, H. O. & Bang, J. (1943). Involvement of the central nervous system in mumps. Acta Med Scand 113, 487-505.
10. Bankamp, B., Kearney, S. P., Liu, X., Bellini, W. J. & Rota, P. A. (2002). Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay. J Virol 76, 7073-7081.
11. Beghi, E., Nicolosi, A., Kurland, L. T., Mulder, D. W., Hauser, W. A. & Shuster, L. (1984). Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology. Ann Neurol 16, 283-294.
12. Brown, E. G., Dimock, K. & Wright, K. E. (1996). The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J Infect Dis 174, 619-622.
13. Buchholz, U. J., Finke, S. & Conzelmann, K. K. (1999). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73, 251-259.
14. Caksen, H. & Ustunbas, H. B. (2003). A fatal case of acute transverse myelitis associated with mumps. J Emery Med 24, 341-342.
15. Carbone, K. M. & Rubin, S. (2007). Mumps virus. In Fields Virology, 5th edn, pp. 1527-1542. Edited by D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Strauss. Philadelphia: Lippincott Williams & Wilkins.
16. Centers for Disease Control and Prevention (2006). Mumps epidemic - Iowa, 2006. MMWR Morb Mortal Wkly Rep 55, 366-368.
17. Clarke, D. K., Sidhu, M. S., Johnson, J. E. & Udem, S. A. (2000). Rescue of mumps virus from cDNA. J Virol 74, 4831-4838.
18. Cohen, H. A., Ashkenazi, A., Nussinovitch, M., Amir, J., Hart, J. & Frydman, M. (1992). Mumps-associated acute cerebellar ataxia. Am J Dis Child 146, 930-931.
19. Conzelmann, K. K. (2004). Reverse genetics of mononegavirales. Curr Top Microbiol Immunol 283, 1-41.
20. Crennell, S., Takimoto, T., Portner, A. & Taylor, G. (2000). Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 7, 1068-1074.
21. Elango, N., Varsanyi, T. M., Kovamees, J. & Norrby, E. (1988). Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol 69, 2893-2900.
22. Furesz, J. & Contreras, G. (1990). Vaccine-related mumps meningitis - Canada. Can Dis Wkly Rep 16, 253-254.
23. Galazka, A. M., Robertson, S. E. & Kraigher, A. (1999). Mumps and mumps vaccine: a global review. Bull World Health Organ 77, 3-14.
24. Gupta, R. K, Best, J. & MacMahon, E. (2005). Mumps and the UK epidemic 2005. BMJ 330, 1132-1135.
25. Jablonski, S. A., Luo, M. & Morrow, C. D. (1991). Enzymatic activity of poliovirus RNA polymerase mutants with single amino acid changes in the conserved YGDD amino acid motif. J Virol 65, 4565-4572.
26. Kovamees, J., Rydbeck, R., Orvell, C. & Norrby, E. (1990). Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res 17, 119-129.
27. Liu, Y., Zhu, J., Feng, M. G., Tien, P. & Gao, G. F. (2004). Six-helix bundle assembly and analysis of the central core of mumps virus fusion protein. Arch Biochem Biophys 421, 143-148.
28. Love, A., Rydbeck, R., Kristensson, K., Orvell, C. & Norrby, E. (1985). Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol 53, 67-74.
29. McGinnes, L., Sergel, T., Reitter, J. & Morrison, T. (2001). Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity. Virology 283, 332-342.
30. Merz, D. C., Server, A. C., Waxham, M. N. & Wolinsky, J. S. (1983). Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursor. J Gen Virol 64, 1457-1467.
31. Miller, E., Goldacre, M., Pugh, S., Colville, A., Farrington, P., Flower, A., Nash, J., MacFarlane, L. & Tettmar, R. (1993). Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 341, 979-982.
32. Moll, M., Kaufmann, A. & Maisner, A. (2004). Influence of N-glycans on processing and biological activity of the Nipah virus fusion protein. J Virol 78, 7274-7278.
33. Moss, B., Elroy-Stein, O., Mizukami, T., Alexander, W. A. & Fuerst, T. R. (1990). New mammalian expression vectors. Nature 348, 91-92.
34. Muller, R., Poch, O., Delarue, M., Bishop, D. H. & Bouloy, M. (1994). Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol 75, 1345-1352.
35. Ogata, H., Oka, K. & Mitsudome, A. (1992). Hydrocephalus due to acute aqueductal stenosis following mumps infection: report of a case and review of the literature. Brain Dev 14, 417-419.
36. Okazaki, K., Tanabayashi, K., Takeuchi, K., Hishiyama, M. & Yamada, A. (1992). Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence. Virology 188, 926-930.
37. Paterson, R. G. & Lamb, R. A. (1990). RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol 64, 4137-4145.
38. Peltola, H., Davidkin, I., Paunio, M., Valle, M., Leinikki, P. & Heinonen, O. P. (2000). Mumps and rubella eliminated from Finland. JAMA 284, 2643-2647.
39. Plemper, R. K. & Compans, R. W. (2003). Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J Virol 77, 4181-4190.
40. Plumet, S., Herschke, F., Bourhis, J. M., Valentin, H., Longhi, S. & Gerlier, D. (2007). Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2, e279.
41. Poch, O., Sauvaget, I., Delarue, M. & Tordo, N. (1989). Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 8, 3867-3874.
42. Poch, O., Blumberg, B. M., Bougueleret, L. & Tordo, N. (1990). Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71, 1153-1162.
43. Rima, B. K., Roberts, M. W., McAdam, W. D. & Martin, S. J. (1980). Polypeptide synthesis in mumps virus-infected cells. J Gen Virol 46, 501-505.
44. Rotbart, H. A. (2000). Viral meningitis. Semin Neurol 20, 277-292.
45. Rubin, S. A., Pletnikov, M., Taffs, R., Snoy, P. J., Kobasa, D., Brown, E. G., Wright, K E. & Carbone, K. M. (2000). Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol 74, 5382-5384.
46. Rubin, S. A., Amexis, G., Pletnikov, M., Li, Z., Vanderzanden, J., Mauldin, J., Sauder, C., Malik T., Chumakov, K. & Carbone, K. M. (2003). Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 77, 11616-11624.
47. Rubin, S. A., Afzal, M. A., Powell, C. L., Bentley, M. L., Auda, G. R., Taffs, R. E. & Carbone, K. M. (2005). The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J Infect Dis 191, 1123-1128.
48. Savage, E., Ramsay, M., White, J., Beard, S., Lawson, H., Hunjan, R. & Brown, D. (2005). Mumps outbreaks across England and Wales in 2004: observational study. BMJ 330, 1119-1120.
49. Segawa, H., Yamashita, T., Kawakita, M. & Taira, H. (2000). Functional analysis of the individual oligosaccharide chains of Sendai virus fusion protein. J Biochem (Tokyo) 128, 65-72.
50. Sergel, T., McGinnes, L. W., Peeples, M. E. & Morrison, T. G. (1993). The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 193, 717-726.
51. Server, A. C., Smith, J. A., Waxham, M. N., Wolinsky, J. S. & Goodman, H. M. (1985). Purification and amino-terminal protein sequence analysis of the mumps virus fusion protein. Virology 144, 373-383.
52. Slater, P. E., Anis, E. & Leventhal, A. (1999). The control of mumps in Israel. Eur J Epidemiol 15, 765-767.
53. Smallwood, S., Hovel, T., Neubert W. J. & Moyer, S. A. (2002). Different substitutions at conserved amino acids in domains II and III in the Sendai L RNA polymerase protein inactivate viral RNA synthesis. Virology 304, 135-145.
54. Sugiura, A. & Yamada, A. (1991). Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 10, 209-213.
55. Tanabayashi, K., Takeuchi, K., Okazaki, K., Hishiyama, M. & Yamada, A. (1992). Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology 187, 801-804.
56. Timmons, G. D. & Johnson, K. P. (1970). Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med 283, 1505-1507.
57. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76, 4350-4354.
58. Tsurudome, M., Yamada, A., Hishiyama, M. & Ito, Y. (1986). Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. J Gen Virol 67, 2259-2265.
59. Ueda, K., Miyazaki, C., Hidaka, Y., Okada, K., Kusuhara, K. & Kadoya, R. (1995). Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 346, 701-702.
60. von Messling, V. & Cattaneo, R. (2003). N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. J Virol 77, 10202-10212.
61. von Messling, V., Milosevic, D., Devaux, P. & Cattaneo, R. (2004). Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function. J Virol 78, 7894-7903.
62. Waxham, M. N., Server, A. C., Goodman, H. M. & Wolinsky, J. S. (1987). Cloning and sequencing of the mumps virus fusion protein gene. Virology 159, 381-388.
63. Wyatt, L. S., Moss, B. & Rozenblatt S. (1995). Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210, 202-205.
64. Zimmer, G., Trotz, I. & Herder, G. (2001). N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J Virol 75, 4744-4751.